STENTIT
STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.
STENTIT
Social Links:
Industry:
Medical
Founded:
2015-01-01
Address:
Eindhoven, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.stentit.com
Total Employee:
11+
Status:
Active
Contact:
+31 (0)40 247 2445
Email Addresses:
[email protected]
Total Funding:
1.8 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API WordPress LetsEncrypt Font Awesome Apache Wordpress Plugins Microsoft Azure DNS
Similar Organizations
epHealth
Proactive Care begins today!
Stem Cell Reserve
Revolutionizing Regenerative Medicine.
Current Employees Featured
Founder
Investors List
Ten Cate Investeringsmaatschappij
Ten Cate Investeringsmaatschappij investment in Seed Round - STENTiT
NextGen Ventures
NextGen Ventures investment in Seed Round - STENTiT
BOM Brabant Ventures
BOM Brabant Ventures investment in Seed Round - STENTiT
EIT Health
EIT Health investment in Grant - STENTiT
Official Site Inspections
http://www.stentit.com Semrush global rank: 14.66 M Semrush visits lastest month: 37
- Host name: cl05.keurigonline.nl
- IP address: 5.22.249.25
- Location: Gieterveen Netherlands
- Latitude: 53.0251
- Longitude: 6.838
- Timezone: Europe/Amsterdam
- Postal: 9511
More informations about "STENTiT"
STENTIT – The next generation in stent technology.
STENTiT aims to redefine the landscape of endovascular treatments with the Resorbable Fibrillated Scaffold (RFS): a temporary vascular support structure capable of reconstructing the artery to …See details»
About Us – STENTIT
STENTiT is a Dutch MedTech company aiming to transform vascular reconstruction. Our innovative approach focuses on developing the Resorbable Fibrillated Scaffold (RFS), capable of triggering …See details»
STENTiT - Crunchbase Company Profile & Funding
STENTiT is a medical device company that focuses on the development of regenerative endovascular implants.See details»
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel ...
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a …See details»
STENTiT | EuroQuity
About your organization / profile STENTiT is a Dutch MedTech company aiming to transform vascular reconstruction. Our innovative approach focuses on developing the Resorbable …See details»
Press Release Distribution and Management - GlobeNewswire
Jun 26, 2025 GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.See details»
STENTiT - News & Analysis - Crunchbase
Jun 26, 2025 STENTiT is a medical device company that focuses on the development of regenerative endovascular implants.See details»
STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel ...
Jun 26, 2025 STENTiT’s RFS device is a bioresorbable stent built from microfibers, providing structural support to instantly open, and facilitate the reconstruction of the artery. Due to the …See details»
STENTiT - Growth Outlook - Crunchbase
STENTiT is a medical device company that focuses on the development of regenerative endovascular implants.See details»
Stentit B.V. | EIC Accelerator Winner | EIC Accelerator Winners
THE NEXT STENT GENERATION: A FIRST-IN-CLASS REGENERATIVE NANOFIBER STENT TO RECONSTRUCT ARTERIES FROM THE INSIDE OUTSee details»
STENTiT - Smart BioMaterials Consortium
STENTiT, Vivolta, & Corbion: Pioneers in Clinical-Grade Stent Manufacturing This groundbreaking project is not just about innovation; it’s about translational steps towards real-world application. The partnership between STENTiT, Vivolta, and …See details»
Stentit’s CEO on Regenerating Arteries with Biodegradable Stents
In this exclusive MedTech World interview, Bart Sanders, CEO and founder of STENTiT, shares how his team is pioneering a first-of-its-kind regenerative stent that transforms into a living artery.See details»
STENTiT 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for STENTiT. Use the PitchBook Platform to explore the full profile.See details»
STENTiT - High Tech Campus
STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants.See details»
STENTiT Enrolls First Patient in Clinical Trial Evaluating
Jun 26, 2025 STENTiT’s RFS device is a bioresorbable stent built from microfibers, providing structural support to instantly open, and facilitate the reconstruction of the artery.See details»
STENTiT Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for STENTiT. See STENTiT company profile and funding data.See details»
STENTiT - LinkedIn
STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable …See details»
TU/e Spin-off STENTiT Debuts Regenerative Stent - Mirage News
Jul 5, 2025 STENTiT is supported by the European Innovation Council and is part of the 2025 MedTech Innovator cohort . /TU/e Public Release. This material from the originating …See details»
StenTiT - Medtech - Nextgen Ventures
STENTiT is developing a biodegradable stent that restores blood flow in severe peripheral artery disease and promotes regeneration of healthy vascular tissue. The stent is both regenerative and …See details»
STENTiT Initiates First-in-Human Trial of Regenerative Stent for ...
Jun 27, 2025 - STENTiT has successfully implanted its first Resorbable Fibrillated Scaffold (RFS) in a patient with chronic limb-threatening ischemia below-the-knee as part of the VITAL-IT 1 clinical …See details»